[ad_1]
Nestle on Thursday posted worse-than-expected results for the first nine months of 2023 as the company’s CEO said the firm is now working on a new range of goods to “serve as companion products” to weight-loss drugs that pose a threat to the confectionary company’s revenue.
The Swiss multinational told investors its revenues had dropped 0.4% year-on-year, to ₣68.83 billion ($76.59 billion) in the first nine months of 2023, due to unfavorable currency exchange rates and divestments.
The…
[ad_2]
Source link
